Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 20 (6), 819-824
- https://doi.org/10.1016/s0168-8278(05)80155-2
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.The Journal of Experimental Medicine, 1993
- Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patientsHepatology, 1991
- Cellular targets and receptors for interleukin‐6 I. In vivo and in vitro uptake of IL‐6 in liver and hepatocytesEuropean Journal of Clinical Investigation, 1990
- Plasma Tumor Necrosis Factor α Predicts Decreased Long‐Term Survival in Severe Alcoholic HepatitisAlcohol, Clinical and Experimental Research, 1990
- Excessive In Vitro Bacterial Lipopolysaccharide–Induced Production of Monokines in CirrhosisHepatology, 1990
- Tumor Necrosis Factor α Production by Peripheral Blood Mononuclear Cells of Patients With Chronic Liver DiseaseHepatology, 1989
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSESThe Lancet, 1987
- Problems of bacterial infection in patients with liver disease.Gut, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986